Sissetulev kiriAvalik
Järelepärimine
Ravimiamet · 19. august 2025
- Viit
- RST-1/4289-1
- Registreeritud
- 19. august 2025
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- Sumitomo Seika
- Saabumis/saatmisviis
- e-post
- Funktsioon
- RST Ravimistatistika tegemine
- Sari
- RST-1 Ravimistatistika alane kirjavahetus
- Toimik
- RST-1/2025
- Vastutaja
- Janne Sepp (RA, Peadirektori asetäitja valdkond, Ravimiohutuse osakond, Statistikabüroo)
- Lahendamise tähtaeg
- 13. august 2025
Failid
Sisu (failidest)
Saatja: "アンジェル アルベルト ヌネズ マグロ" <[email protected]>
Saaja: "Ravimiamet" <[email protected]>
Teema: RE: Data about Quetiapine and Etoricoxib
Kuupäev: 2025-07-29 05:51
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.
Dear Ravimiamet
My name is Alberto Nunez and I belong to sales department of gas and
chemical division in Sumitomo Seika Japan
I am looking for some data about the consumption (both amount and sales) of
the bellow medicines in Estonia
* Quetiapine (ATC: N05AH04)
* Etoricoxib (ATC: M01AH05)
I wonder if there is any source of raw data of medicine consumption in
Estonia. If so, would you please let me know how to access?
Thank you very much for your time
Alberto
_____
Dr Angel Alberto Núñez Magro Phd MBA Msc BEng.
Chemical and gas division
Sales manager
Sumitomo Seika
1-13-5 Kudan kita, Chiyoda-ku, Tokyo 102-0073
<Tel:+81-80-> Tel:+81-80-8318-1659
Linkedin: <https://www.linkedin.com/in/angelalbertonunezmagro/>
https://www.linkedin.com/in/angelalbertonunezmagro/
Mail: <mailto:[email protected]> [email protected]
_____